Inhibitors of apoptosis proteins in prostate cancer cell lines

Prostate - Tập 51 Số 2 - Trang 133-140 - 2002
Kevin McEleny1,2, J. M. Fitzpatrick1, Ronan Coffey1, Amanda O’Neill1, John M. Fitzpatrick1
1Department of Surgery, Mater Misericordiae Hospital, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland
2KmcE was funded by the Royal College of Surgeons of England and is a British Urological Foundation/Yamanouchi scholar.

Tóm tắt

AbstractBACKGROUNDThe caspases are the central executioners of apoptosis. The inhibitors of apoptosis proteins (IAPs) are a family of recently described caspase inhibitors. We hypothesised that tumor resistance to apoptosis could be due in part to IAP expression.METHODSThe expression of NAIP, cIAP‐1, cIAP‐2, XIAP, and survivin was investigated in the prostate cancer cell lines LNCaP, PC3, and DU145. RNase protection assays and Western blotting were used to assess RNA and protein expression. Apoptotic susceptibility was determined using etoposide and assessed by propidium iodide (PI) DNA incorporation using flow cytometry.RESULTSDU145 and PC3 cells were more resistant to apoptosis than LNCaP cells. All the IAPs were identified in the cell lines with variation in IAP expression between different cell types. Immunohistochemistry demonstrated cIAP‐1 expression in PC3 cells was nuclear, while the expression of cIAP‐2 and XIAP was perinuclear. Growing LNCaP cells in charcoal‐stripped or androgen‐supplemented medium resulted in no alteration in IAP expression.CONCLUSIONSThis study characterises the expression of IAP in three of the most commonly used prostate cancer cells. IAP may make an important contribution to apoptotic resistance in patients with prostate cancer. Prostate 51: 133–140, 2002. © 2002 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1046/j.1464-410x.1999.00954.x

10.1046/j.1464-410X.2000.00057.x

Clem RJ, 1994, Control of programmed cell death by the Baculovirus genes p35 and iap, Mol Biol Cell, 14, 5212

10.1016/0092-8674(95)90150-7

10.1038/sj.onc.1202569

10.1006/bbrc.1999.1585

10.1074/jbc.M003670200

Tamm I, 1998, IAP‐Family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs, Cancer Res, 58, 5315

10.1038/sj.onc.1202021

10.1093/emboj/17.8.2215

10.1073/pnas.94.19.10057

10.1084/jem.188.1.211

10.1128/jvi.71.6.4509-4516.1997

10.1093/emboj/16.23.6914

10.1093/emboj/17.8.2215

10.1002/pros.1061

10.1002/(SICI)1097-0215(19970127)70:3<341::AID-IJC16>3.0.CO;2-I

10.1038/nm0897-917

Tanaka K, 2000, Expression of survivin and its relationship to loss of apoptosis in breast carcinomas, Clin Cancer Res, 6, 127

Lu C‐D, 1998, Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas, Cancer Res, 58, 1808

Kawasaki H, 1998, Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer, Cancer Res, 58, 5071

10.1136/gut.46.5.645

10.1016/S0140-6736(05)70294-4

10.1038/sj.onc.1203358

10.1200/JCO.1999.17.7.2100

10.1038/sj.neo.7900091

Olie RA, 2000, A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitises lung cancer cells to chemotherapy, Cancer Res, 60, 2805

10.1046/j.1523-1747.1999.00776.x

10.1053/he.2000.6496

10.1038/sj.cdd.4400503

Tamm I, 2000, Expression and prognostic significance of IAP‐family genes in human cancers and myeloid leukaemias, Clin Cancer Res, 6, 1796

10.1016/0092-8674(95)90461-1

Seidl R, 1999, Neuronal apoptosis inhibitory (NAIP)‐like immunoreactivity in brains of adult patients Down syndrome, J Neural Transm, 57, 283

Miyake H, 2000, Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene Testosterone‐repressed ProstateMessage‐2 in prostate cancer xenograft models, Cancer Res, 60, 2547

Hiromitsu M, 2000, Expression of the IAP (inhibitor of apoptosis protein) gene family in prostate cancer, Eur Urol, 37, 104

10.1038/25141

Tang DG, 1998, Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins, Cancer Res, 58, 3466

Berchem G, 1995, Androgens induce resistance to Bcl‐2‐mediated apoptosis in LNCaP prostate cancer cells, Cancer Res, 55, 735

Tso C, 2000, Androgen deprivation induces selective outgrowth of aggressive hormone‐refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen‐dependent cancer cells, Cancer J, 6, 213

Krajewska M, 1996, Immunohistochemical analysis of Bcl‐2, bax, Bcl‐x, and mcl‐1 expression in prostate cancers, Am J Pathol, 148, 1567

Thông tin
Thông tin xuất bản

Prostate

Tập 51 Số 2

133-140

Thông tin tác giả